Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation.

Next-Generation Artificial Intelligence for Diagnosis: From Predicting Diagnostic Labels to "Wayfinding".

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.

Patient age: a neglected factor when considering disease management in adults with type 2 diabetes.

Cystic Fibrosis Lung Transplant Recipients Have Suppressed Airway Interferon Responses during Pseudomonas Infection.

Robert Russo, MD

Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma.

Association Between Intensive vs Standard Blood Pressure Control and Incident Left Ventricular Conduction Disease: A Post Hoc Analysis of the SPRINT Randomized Clinical Trial.

Multicenter study of Clostridium difficile infection rates from 2000 to 2006.

Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.

Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome.

Angela Suen Publishes in CHEST on End-of-Life Care Utilization

Angela Suen, MD, has published a study in CHEST titled "Differences in Healthcare and Palliative Care Utilization at the End of Life: A Comparison Study Between Lung Cancer, COPD, and IPF." The study found that individuals with COPD and IPF had lower rates of palliative care utilization and higher rates of intensive care at the end of life compared to those with lung cancer. Dr. Suen conducted this research at UCSF under the mentorship of Dr. Ashwin Kotwal and Dr. Rebecca Sudore.

Role and regulation of sigma S in general resistance conferred by low-shear simulated microgravity in Escherichia coli.

Diastolic dysfunction and congestive heart failure.

Medical Need and Transplant Accessibility-Reply.